The cardiologists were the top specialty prescribed GLP-1RAs for type 2 diabetes, 84 percent, while 44 percent of orthopaedics reporting having done so, with 52 to 88 percent of the other surveyed specialists reporting such prescriptions
Jones RN, Ferraro MJ, Reller LB, Schreckenberger PC, Swenson JM, Sader HS
Currently, retatrutide is in Phase 3 trials that could be released by the end of this year
Key Indications Musculoskeletal Injuries: Promotes faster wound healing and enhances recovery from tendon, ligament, and muscle injuries
That preservative prevents microbial growth in the solution after the vial is opened
We build lifestyle work into the visits from day one instead of treating it as an afterthought, because the medication is a tool that works while you are on a monitored plan, not a permanent fix on its own